Cross-channel message consistency in herbal medicine advertising

Author(s):  
Abena Animwaa Yeboah-Banin ◽  
Kwaku Krobea Asante

Purpose For many developing country citizens, traditional herbal medicines offer affordable alternatives to expensive orthodox options. Consumers learn about them from different sources including the packaging, which by regulatory demands must provide certain information. In countries such as Ghana, many herbal medicine brands combine packaging information with radio presenter mentions (PMs) as the primary modes of advertising. The purpose of this study is to compare radio PMs of herbal medicines to their packaging information to see how consistent they are in providing credible information to consumers. Design/methodology/approach The study uses comparative qualitative content analysis to compare information about disease indications, directions for use and warnings/cautions as provided on the packaging and in PMs to gauge the extent of their congruence. Findings Findings show that there are substantial cross-channel message differences. These differences range from under-representation to sometimes, blatant misinformation, suggesting the possibility that audiences will have difficulty relying on them for decisions. Research limitations/implications This study only addressed issues with the manifest content of herbal drugs’ packaging and PMs. It does not include any interviews with consumers to gauge the extent of their consciousness of the lapses identified, and how they are affected by such. In addition, the study sample is context-specific. Ghana presents an interesting setting for the study but it is none-the-less only one country, denying us the power to generalize the findings. Practical implications The study points to a need to pay closer attention to message salience and consistency where multiple channels are used in promoting herbal medicinal products. Due to their historically traditional context of consumption in many developing countries, regulatory frameworks on herbal medicine markets are often lax. This study calls attention to a need for better policing on how herbal medicinal products promote themselves, particularly where they use multiple media channels that introduce variations into their messages. Originality/value The study calls attention to the credibility of cross-channel messages in supporting consumers of medicinal products. Secondly, because of the predominance of the normative view in medical advertising, channels such as PMs that accommodate message variation and improvisation have eluded critical analysis. By its focus on the presenter mention advertising format, the study also draws attention of health communication scholars to begin to include emerging modes of medical advertising in their analysis.

2020 ◽  
Vol 1 (3) ◽  
pp. 149-154
Author(s):  
Himmatul Miftah ◽  
Ita Novita ◽  
H Tsuwaibah ◽  
M. A. Sunaryo

Abstract: The emergence of a wide variety of herbal medicinal products requires marketers to better understand consumer behavior. The various brands offered make consumers tend to have certain preferences before making a purchase decision. This study aims to determine the attributes of herbal medicinal products that determine the level of consumer preference in the purchasing process and the closeness of the attributes to consumer preferences. The method used is interviews with consumers which are then processed with conjoint analysis to determine the attributes that are most important to consumers in making a purchase. The research concludes that the most important attributes in purchasing herbal medicine in order from the most important are the properties, price, expiration time and packaging. There is a close relationship between the combination of attributes studied and consumer preferences for herbal medicine. This study is limited to four attributes and does not use ranking ratings on the stimulus or combination of attributes, consumer behavior. The uniqueness of this study is to analyze the attributes simultaneously.   Keywords: Herbal medicine product attributes, consumer preferences, conjoin analysis, level of importance


2019 ◽  
Vol 179 (3) ◽  
pp. 507-512
Author(s):  
Karen Nieber ◽  
Esther Raskopf ◽  
Johanna Möller ◽  
Olaf Kelber ◽  
Robert Fürst ◽  
...  

AbstractIn paediatrics, clinical study data are limited, especially on herbal medicinal products. To address this gap, 2063 datasets from the paediatric population were evaluated in the PhytoVIS data base. By screening for paediatric data, information on indication, gender, treatment, co-medication and tolerability were evaluated. The majority of patients was treated because of common cold, fever, digestive complaints, skin diseases, sleep disturbances and anxiety. The perceived effect of the therapy was rated in 84% of the patients as very good or good without adverse events. The data shed light on a still neglected field of phyto-pharmacotherapy by giving information on the use of herbal medicines in an unselected cohort of paediatric patients. The results confirm the good clinical effects and safety of herbal medicinal products in this patient population and show that they are widely used in Germany.What is Known:• In Germany, about 85% of children receive one or more herbal medicinal products per year.• Despite international initiatives to promote clinical research in paediatrics, there are still many gaps of knowledge in the use of drugs in paediatrics.What is New:• The PhytoVIS project evaluated 2063 data sets from the paediatric population using herbal medicinal products.• The majority of patients was treated because of common cold, fever, digestive complaints, skin diseases, sleep disturbances and anxiety, and 84% of the patients rated the therapy as very good or good without adverse events.


2021 ◽  
Vol 19 ◽  
Author(s):  
Thomas Brendler ◽  
Josef A. Brinckmann ◽  
Ulrich Feiter ◽  
Nigel Gericke ◽  
Lucy Lang ◽  
...  

: Modern-day regulatory systems governing conditions for how health products enter national markets constitute a barrier of access for traditional herbal medicines on an international level. Regulatory intentions are focused on ensuring consumers are being provided with safe, efficacious and high-quality products that, however, collaterally limit opportunities for traditional herbal medicinal products, especially those that do not already have a long-standing tradition of use established in the respective national marketplaces. This case study investigates and compares how a Southern African herbal medicine with great potential as an anxiolytic and mild antidepressant – Mesembryanthemum tortuosum L. [syn. Sceletium tortuosum (L.) N.E.Br.] aerial parts – fares internationally in today’s regulatory environments. It is argued that inadvertent regulatory favoritism combined with the lack of means for adequate protection of intellectual property may obstruct innovation by creating an almost insurmountable economical hurdle for successful product development and introduction of botanicals from developing countries into most of the world’s health product markets.


2002 ◽  
Vol 8 (2) ◽  
pp. 72-74 ◽  
Author(s):  
Edzard Ernst

Herbal medicinal products are often sold as a safe and effective alternative to HRT. Sizeable sets of trial data exist for black cohosh and soy. For other herbal medicines, only isolated trials have emerged, and their number is too low to enable one to arrive at valid conclusions. Collectively the data for black cohosh do not prove efficacy. The evidence for soy is encouraging but not compelling. Neither black cohosh nor soy is associated with major safety problems. Further research is warranted to closer define the role of herbal medicines for the menopause.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Michela Luisa De Pellegrin ◽  
Anette Rohrhofer ◽  
Philipp Schuster ◽  
Barbara Schmidt ◽  
Philipp Peterburs ◽  
...  

Abstract Background Herbal medicinal products have a long-standing history of use in the therapy of common respiratory infections. We sought to assess the potential of five validated herbal extracts regarding their ability to restrict SARS-CoV-2 replication in vitro: Bronchipret thyme-ivy (BRO TI), Bronchipret thyme-primrose (BRO TP), Imupret (IMU), Sinupret extract (SINx) and Tonsipret (TOP). Methods Vero cells were incubated with different concentrations of herbal extracts and infected with SARS-CoV-2 for 48 hours. The inhibition of viral replication was assessed by determination of the viral RNA load in the cell culture supernatant using quantitative polymerase chain reaction (qPCR). Results SARS-CoV-2 RNA load was reduced by non-cytotoxic concentrations of BRO-TP (up to approximately 1,000-fold) and, to a lesser extent, IMU and TOP (approximately 10-fold). Conclusions Some herbal extracts showed a promising in vitro effectiveness against SARS-CoV-2, suggesting an antiviral potential of herbal medicinal products. The potential of herbal medicines to restrict SARS-CoV-2 and to treat COVID-19 should be investigated further in a clinical setting.


Author(s):  
O. V. Evdokimova ◽  
A. V. Beketova ◽  
M. N. Lyakina

The relevance of this study stems from the need for alignment of test methods used for identification and assay of anthracene derivatives in herbal preparations and herbal medicinal products. The aim of the study was to analyse Russian and international quality standards and to identify the most specific and sensitive test methods that could be used for herbal medicines containing anthracene derivatives. The comparative analysis of requirements in the Identification, Determination of major classes of bioactive compounds, and Assay parts of the Russian and foreign pharmacopoeial monographs for herbal preparations and herbal medicinal products containing anthracene derivatives, demonstrated that the main test method used for identification is thin layer chromatography, while assays most often rely on spectrophotometry. The so-called “consistent standardisation” principle is implemented in the Russian quality standards as regards alignment of methods used for anthracene derivative determination in herbal preparations (i.e. active pharmaceutical ingredients, APIs) and herbal medicinal products containing these APIs. The comparative analysis of requirements in the Russian and foreign quality standards for herbal medicines containing anthracene derivatives demonstrated the need for elaboration of two general chapters: Qualitative analysis of anthracene derivatives in herbal medicines and Quantitative analysis of anthracene derivatives in herbal medicines.


2011 ◽  
Vol 47 (2) ◽  
pp. 269-277 ◽  
Author(s):  
Sandra Alves de Sousa ◽  
Henrique Pascoa ◽  
Edemilson Cardoso da Conceição ◽  
Suzana Ferreira Alves ◽  
Danielle Guimarães Almeida Diniz ◽  
...  

"Guaraná" (Paullinia cupana) is used as a physical activity enhancer and stimulator due to its methylxanthines and condensed tannins. The aim of this work was to evaluate the dissolution behavior of five herbal medicines in the form of capsules and tablets containing guaraná. Assay and dissolution methods were validated and results obtained allowed simultaneous marker quantification with precision, accuracy, selectivity and robustness. Findings showed that 100% of the herbal medicinal products analyzed did not provide satisfactory results concerning the presence of four markers, 60% had three markers (caffeine, catechin and epicatechin), while 40% had only caffeine at tested dosage forms. In addition, after 30 minutes, only capsule A showed at least 80% of the dissolved markers. In other capsules, marker dissolution did not exceed 60% whereas 60% of the samples had some characteristic pharmacotechnical problems. These results evidence the need for rigorous quality control to help ensure the therapeutic action of these drugs. To this end, dissolution studies are an essential tool for quality assurance of herbal medicines.


Sign in / Sign up

Export Citation Format

Share Document